1
项与 JNJ-75229414 相关的临床试验A Phase 1, Dose Escalation Study of JNJ-75229414, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against KLK2 for Metastatic Castration-Resistant Prostate Cancer
The purpose of this study is to determine recommended Phase 2 dose (RP2D) regimen(s) of JNJ-75229414 in Part 1 (Dose Escalation and to determine safety at the RP2D regimen(s) in Part 2 (Dose Expansion).
100 项与 JNJ-75229414 相关的临床结果
100 项与 JNJ-75229414 相关的转化医学
100 项与 JNJ-75229414 相关的专利(医药)
100 项与 JNJ-75229414 相关的药物交易